title: CA 15-3 is a predictive and prognostic biomarker in patients with metastasized breast cancer undergoing Selective Internal Radiation Therapy.
authors.affiliation: Institute of Clinical Chemistry, University-Hospital Munich-Grosshadern, Munich, Germany.
authors.forename: Yvonne Nadine
authors.initials: YN
authors.lastname: Fahmueller
authors.forename: Dorothea
authors.initials: D
authors.lastname: Nagel
authors.forename: Ralf-Thorsten
authors.initials: RT
authors.lastname: Hoffmann
authors.forename: Klaus
authors.initials: K
authors.lastname: Tatsch
authors.forename: Tobias
authors.initials: T
authors.lastname: Jakobs
authors.forename: Petra
authors.initials: P
authors.lastname: Stieber
authors.forename: Stefan
authors.initials: S
authors.lastname: Holdenrieder
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood* / Q000532:radiotherapy* / Q000556:secondary; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D016019:Survival Analysis
chemical_list: D014408:Biomarkers, Tumor; D018396:Mucin-1